Download - india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Transcript

Page 1: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 2: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 3: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 4: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 5: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 6: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 7: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 8: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 9: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 10: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Page 11: india-pharma.gsk.com€¦ · Present : PI g.. 60.9. B E.. ..ßâu.Ô bet; —40062—4 subsidiaries of the Other consider- ation paid Date of disposal for Permanent . Sr. No. (1)

Top Related

Extraordinary - india-pharma.gsk.com · 20. Pursuant to Finance Act, 2020, dividend income will be taxable in the hands of shareholders w.e.f. 1 April 2020 and the company is required

Extraordinary - india-pharma.gsk.com · 20. Pursuant to Finance Act, 2020, dividend income will be taxable in the hands of shareholders w.e.f. 1 April 2020 and the company is required

Bond University Research Repository Load Carriage: An ... · OPERATIONAL LOAD CARRIAGE (Marching Order) The Australian Soldier Context Mean Marching Order Loads (M only) 61.2 60.9

Bond University Research Repository Load Carriage: An ... · OPERATIONAL LOAD CARRIAGE (Marching Order) The Australian Soldier Context Mean Marching Order Loads (M only) 61.2 60.9

ASRM Scientific Paper Presentations: Head January 19, 2016 – … · Results: Of 294 cases, 179 (60.9%) required neck skin resurfacing and 115 (38.1%) were closed primarily. In the

ASRM Scientific Paper Presentations: Head January 19, 2016 – … · Results: Of 294 cases, 179 (60.9%) required neck skin resurfacing and 115 (38.1%) were closed primarily. In the

Prophylaxis of chemotherapy-induced febrile ... - srh.org.ro · Figure 1. 2010 updated EORTC guideline algorithm Table 1. Patient characteristics Gender Male Female 39.1 % 60.9% Age

Prophylaxis of chemotherapy-induced febrile ... - srh.org.ro · Figure 1. 2010 updated EORTC guideline algorithm Table 1. Patient characteristics Gender Male Female 39.1 % 60.9% Age

Scott Steinmaus, PhD - Monterey Countycemonterey.ucdavis.edu/files/132407.pdfdensities ranged from 7.9 to 60.9 million seeds /A. (Battista 1998). • In the Salinas Valley, seedbank

Scott Steinmaus, PhD - Monterey Countycemonterey.ucdavis.edu/files/132407.pdfdensities ranged from 7.9 to 60.9 million seeds /A. (Battista 1998). • In the Salinas Valley, seedbank

Maximizing access - india-pharma.gsk.comindia-pharma.gsk.com/media/711802/annual-report-2012.pdf · GSK practices its belief in maximizing access to medicines for all. GSK continues

Maximizing access - india-pharma.gsk.comindia-pharma.gsk.com/media/711802/annual-report-2012.pdf · GSK practices its belief in maximizing access to medicines for all. GSK continues

Committed to Serve Fast-forward the future - GSK Indiaindia-pharma.gsk.com/media/787429/annual-report-2016.pdf · Committed to Serve Fast-forward the future. Annual Report 2015-16

Committed to Serve Fast-forward the future - GSK Indiaindia-pharma.gsk.com/media/787429/annual-report-2016.pdf · Committed to Serve Fast-forward the future. Annual Report 2015-16

india-pharma.gsk.comindia-pharma.gsk.com/media/784055/sexual-harassment...GlaxoSmithKline HR/POL/010/06-2015/Sexual Harassment Policy 1. Purpose STANDARD PROCEDURE GSK PREVENTION OF

india-pharma.gsk.comindia-pharma.gsk.com/media/784055/sexual-harassment...GlaxoSmithKline HR/POL/010/06-2015/Sexual Harassment Policy 1. Purpose STANDARD PROCEDURE GSK PREVENTION OF